210 related articles for article (PubMed ID: 18443094)
1. Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes.
Ivie SE; McClain MS; Torres VJ; Algood HM; Lacy DB; Yang R; Blanke SR; Cover TL
Infect Immun; 2008 Jul; 76(7):2843-51. PubMed ID: 18443094
[TBL] [Abstract][Full Text] [Related]
2. Functional properties of the p33 and p55 domains of the Helicobacter pylori vacuolating cytotoxin.
Torres VJ; Ivie SE; McClain MS; Cover TL
J Biol Chem; 2005 Jun; 280(22):21107-14. PubMed ID: 15817461
[TBL] [Abstract][Full Text] [Related]
3. Analysis of a beta-helical region in the p55 domain of Helicobacter pylori vacuolating toxin.
Ivie SE; McClain MS; Algood HM; Lacy DB; Cover TL
BMC Microbiol; 2010 Feb; 10():60. PubMed ID: 20178613
[TBL] [Abstract][Full Text] [Related]
4. A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain.
González-Rivera C; Campbell AM; Rutherford SA; Pyburn TM; Foegeding NJ; Barke TL; Spiller BW; McClain MS; Ohi MD; Lacy DB; Cover TL
Infect Immun; 2016 Sep; 84(9):2662-70. PubMed ID: 27382020
[TBL] [Abstract][Full Text] [Related]
5. Structural organization of membrane-inserted hexamers formed by Helicobacter pylori VacA toxin.
Pyburn TM; Foegeding NJ; González-Rivera C; McDonald NA; Gould KL; Cover TL; Ohi MD
Mol Microbiol; 2016 Oct; 102(1):22-36. PubMed ID: 27309820
[TBL] [Abstract][Full Text] [Related]
6. Random mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity.
McClain MS; Czajkowsky DM; Torres VJ; Szabo G; Shao Z; Cover TL
Infect Immun; 2006 Nov; 74(11):6188-95. PubMed ID: 16954403
[TBL] [Abstract][Full Text] [Related]
7. A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation.
Vinion-Dubiel AD; McClain MS; Czajkowsky DM; Iwamoto H; Ye D; Cao P; Schraw W; Szabo G; Blanke SR; Shao Z; Cover TL
J Biol Chem; 1999 Dec; 274(53):37736-42. PubMed ID: 10608833
[TBL] [Abstract][Full Text] [Related]
8. Mapping of a domain required for protein-protein interactions and inhibitory activity of a Helicobacter pylori dominant-negative VacA mutant protein.
Torres VJ; McClain MS; Cover TL
Infect Immun; 2006 Apr; 74(4):2093-101. PubMed ID: 16552038
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of the oligomeric states of Helicobacter pylori VacA toxin.
Chambers MG; Pyburn TM; González-Rivera C; Collier SE; Eli I; Yip CK; Takizawa Y; Lacy DB; Cover TL; Ohi MD
J Mol Biol; 2013 Feb; 425(3):524-35. PubMed ID: 23178866
[TBL] [Abstract][Full Text] [Related]
10. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation.
McClain MS; Cao P; Iwamoto H; Vinion-Dubiel AD; Szabo G; Shao Z; Cover TL
J Bacteriol; 2001 Nov; 183(22):6499-508. PubMed ID: 11673417
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain.
Gangwer KA; Mushrush DJ; Stauff DL; Spiller B; McClain MS; Cover TL; Lacy DB
Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16293-8. PubMed ID: 17911250
[TBL] [Abstract][Full Text] [Related]
12. Oxidative Products of Curcumin Rather Than Curcumin Bind to
Chaturvedi M; Mishra M; Pandey A; Gupta J; Pandey J; Gupta S; Malik MZ; Somvanshi P; Chaturvedi R
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235264
[TBL] [Abstract][Full Text] [Related]
13. Interactions between p-33 and p-55 domains of the Helicobacter pylori vacuolating cytotoxin (VacA).
Torres VJ; McClain MS; Cover TL
J Biol Chem; 2004 Jan; 279(3):2324-31. PubMed ID: 14593124
[TBL] [Abstract][Full Text] [Related]
14. Functional Properties of Oligomeric and Monomeric Forms of Helicobacter pylori VacA Toxin.
Caso GC; McClain MS; Erwin AL; Truelock MD; Campbell AM; Leasure CS; Nagel M; Schey KL; Lacy DB; Ohi MD; Cover TL
Infect Immun; 2021 Nov; 89(12):e0034821. PubMed ID: 34543122
[TBL] [Abstract][Full Text] [Related]
15. Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA.
Raghunathan K; Foegeding NJ; Campbell AM; Cover TL; Ohi MD; Kenworthy AK
Infect Immun; 2018 May; 86(5):. PubMed ID: 29531133
[No Abstract] [Full Text] [Related]
16. Amino-terminal hydrophobic region of Helicobacter pylori vacuolating cytotoxin (VacA) mediates transmembrane protein dimerization.
McClain MS; Cao P; Cover TL
Infect Immun; 2001 Feb; 69(2):1181-4. PubMed ID: 11160018
[TBL] [Abstract][Full Text] [Related]
17. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis.
Palframan SL; Kwok T; Gabriel K
Front Cell Infect Microbiol; 2012; 2():92. PubMed ID: 22919683
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of Helicobacter pylori VacA toxin from purified components.
González-Rivera C; Gangwer KA; McClain MS; Eli IM; Chambers MG; Ohi MD; Lacy DB; Cover TL
Biochemistry; 2010 Jul; 49(27):5743-52. PubMed ID: 20527875
[TBL] [Abstract][Full Text] [Related]
19. Expression of Helicobacter pylori vacuolating toxin in Escherichia coli.
McClain MS; Cover TL
Infect Immun; 2003 Apr; 71(4):2266-71. PubMed ID: 12654854
[TBL] [Abstract][Full Text] [Related]
20. Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization.
Su M; Erwin AL; Campbell AM; Pyburn TM; Salay LE; Hanks JL; Lacy DB; Akey DL; Cover TL; Ohi MD
J Mol Biol; 2019 May; 431(10):1956-1965. PubMed ID: 30954575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
